Pharma’s post-COVID prospects: the pharmaphorum podcastIn this latest podcast, pharmaphorum spoke to Andrew Meade, life sciences lead UK and Ireland at Accenture, about Share XPharma’s post-COVID prospects: the pharmaphorum podcasthttps://pharmaphorum.com/podcast/pharma-post-covid-prospects-accenture/
How COVID-19 is changing the sales modelThe COVID-19 pandemic means that reps can no longer speak face-to-face with physicians and many HCPs simply don’t Share XHow COVID-19 is changing the sales modelhttps://pharmaphorum.com/views-analysis-sales-marketing/covid-19-changing-sales-model/
Collaborative working is key for the NHS and pharmaBoth the NHS and pharma recognise the need and the opportunity to collaborate in order to improve patient Share XCollaborative working is key for the NHS and pharmahttps://pharmaphorum.com/views-and-analysis/collaborative-working-key-nhs-pharma/
Future-proofing pharma with a multichannel approach to sales and marketingDeploying a multichannel approach to marketing, backed by the use of advanced analytics, could help pharma evolve and Share XFuture-proofing pharma with a multichannel approach to sales and marketinghttps://pharmaphorum.com/views-analysis-sales-marketing/multichannel-marketing-sales-pharma/
